{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:56:03Z","timestamp":1781556963491,"version":"3.54.5"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1995,10]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            It is generally believed that coronary artery spasm plays an important role in the progression of obstructive coronary artery disease. Since insulin resistance together with hyperinsulinemia plays an important role in the pathogenesis of coronary atherosclerosis, we investigated the association of hyperinsulinemia and insulin resistance with vasospastic angina (VAP).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            The study population consisted of 60 patients with VAP and 42 control subjects (62 subjects with normal glucose tolerance and 40 with impaired glucose tolerance). Insulin sensitivity was determined by the steady-state plasma glucose (SSPG) method for nondiabetic, normotensive, nonobese subjects (16 control subjects, 16 obstructive coronary artery disease patients, and 16 VAP patients). Compared with the control groups, the 2-hour insulin area (area under the plasma insulin concentration-time curve) during a 75-g oral glucose tolerance test was significantly higher in both VAP groups with normal and impaired glucose tolerance. A high frequency of vasospastic angina was observed in subjects with clustered risk factors for insulin resistance syndrome, suggesting a close association of VAP with this syndrome. In stepwise discriminant analysis, the 2-hour insulin area was significantly associated with VAP independent of other risk factors. SSPG level in VAP was about twofold over control, indicating the presence of insulin resistance in patients with VAP. However, no differences were found between patients with VAP and obstructive coronary artery disease with respect to mean SSPG level.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            SSPG level was significantly elevated in patients with VAP and obstructive coronary artery disease compared with control subjects. This indicates that hyperinsulinemia is secondary to insulin resistance, both of which are thought to play important roles as risk factors for VAP in the early atheromatous lesion and in the future development of occlusive lesions when chronically present.\n          <\/jats:p>","DOI":"10.1161\/01.cir.92.7.1749","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"1749-1757","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":74,"title":["Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina"],"prefix":"10.1161","volume":"92","author":[{"given":"Kazuya","family":"Shinozaki","sequence":"first","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyoshi","family":"Ikebuchi","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takaki","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Hara","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoo","family":"Tsushima","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Harano","sequence":"additional","affiliation":[{"name":"From the Division of Atherosclerosis, Metabolism, and Clinical Nutrition (K.S., M.S., M.I., Y. Hara, M.T., Y. Harano) and the Division of Cardiology (H.T.), Department of Medicine, National Cardiovascular Center, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.81.2.2105174"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.88.1.8319359"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.89.1.12"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.1.8419026"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.88.5.8222108"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90004-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90006-U"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis. 1993;21(suppl 3):32-38.","DOI":"10.1016\/0272-6386(93)70122-F"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113801"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113276"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113297"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90419-7"},{"key":"e_1_3_2_13_2","first-page":"1595","volume":"37","year":"1989","unstructured":"Reaven GM. Role of insulin resistance in human disease. Diabetes. 1989;37:1595-1607.","journal-title":"Diabetes"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.3.173"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.2.8425301"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Fishman WH. \u03b2-Adrenergic receptor blockers: adverse effects and drug interactions. Hypertension. 1988;11(suppl II):II-21-II-29.","DOI":"10.1161\/01.HYP.11.3_Pt_2.II21"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Weinberger MH. Diuretics and their side effects: dilemma in the treatment of hypertension. Hypertension. 1988;11(suppl II):II-16-II-20.","DOI":"10.1161\/01.HYP.11.3_Pt_2.II16"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198708063170605"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90071-J"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1114"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_3_2_22_2","first-page":"52","volume":"120","year":"1937","unstructured":"Hoffman WS. A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem. 1937;120:52-55.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0880137"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/19.12.1350"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(68)90041-7"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38059-7"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0019-2791(65)90004-2"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.74.6.3779913"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.75.3.3815770"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Harano Y Hidaka H Takatsuki K Ohgaku S Haneda M Motoi S Shigeta Y Abe H. Glucose insulin and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism. 1978;27(suppl I):1449-1452.","DOI":"10.1016\/0026-0495(78)90091-4"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90160-4"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606263142606"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2670(00)85197-1"},{"key":"e_1_3_2_34_2","unstructured":"WHO Study Group. Definition Diagnosis and Classification: Diabetes Mellitus. Technical Report Series 727 World Health Organization. 1985:9-25."},{"key":"e_1_3_2_35_2","first-page":"891","volume":"43","year":"1970","unstructured":"Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Memorandum on classification of hyperlipidemias and hyperlipoproteinemias. Bull World Health Organ. 1970;43:891-898.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.6.631"},{"key":"e_1_3_2_37_2","first-page":"87","volume":"17","year":"1991","unstructured":"Py\u00f6r\u00e4l\u00e4 K. Hyperinsulinemia as predictor of atherosclerotic vascular disease: epidemiological evidence. Diabetes Metab Rev. 1991;17:87-92.","journal-title":"Diabetes Metab Rev"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5646.748"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.11.1.1988007"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6408736"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969509037422"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90619-Z"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Harrison DG Freiman PC Armstrong ML Marcus ML Heistad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res. 1987;61(suppl II):II-74-II-80.","DOI":"10.1161\/res.61.5_supplement.ii-74"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.60.2.3568294"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602203140806"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198808253190802"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198904203201601"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116541"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34343-1"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5724.685"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90616-5"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(78)90691-4"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.69.2.6690108"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90135-6"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.6.715"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","unstructured":"Vallance P Calver A Collier J. The vascular endothelium in diabetes and hypertension. J Hypertens. 1992;10(suppl 2):S25-S29.","DOI":"10.1097\/00004872-199204001-00006"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90745-U"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404136"},{"key":"e_1_3_2_59_2","first-page":"323","volume":"19","year":"1993","unstructured":"Altura BM, Zhang A, Altura BT. Magnesium, hypertensive vascular diseases, atherogenesis, subcellular compartmentation of Ca2+ and Mg2+ and vascular contractility. Miner Electrolyte Metab. 1993;19:323-336.","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1840"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00869264"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.780"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)34071-2"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.21.6.1024"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.79.3.2917390"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)92597-1"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.88.5.8222109"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.2.260"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113088"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114644"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198907000-00006"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.92.7.1749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T15:53:17Z","timestamp":1715529197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.92.7.1749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["10.1161\/01.CIR.92.7.1749"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.92.7.1749","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]},"assertion":[{"value":"1995-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-05-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}